Hu Y, Xu X, Ouyang YB, He C, et al. Optimization of vonoprazan-amoxicillin dual therapy for eradicating Helicobacter pyloriinfection in China: A prospective, randomized clinical pilot study. Helicobacter 2022 Apr 25:e12896. doi: 10.1111/hel.12896.
PMID: 35466521